Community-acquired Staphylococcus aureus pneumonia among hospitalized children in Hawaii

Pediatric Pulmonology

Volumn 45, Issue 9, 2010, Pages 898-905

  Len, Kyra A ^a   Bergert, Lora ^a   Patel, Shilpa ^a,b   Melish, Marian ^a   Kimata, Chieko ^c   Erdem, Guliz ^a  

^a UNIVERSITY OF HAWAII   (United States)

^b STANFORD UNIVERSITY   (United States)

^c STRAUB CLINIC AND HOSPITAL   (United States)

Author keywords

Children; Methicillin resistance; Pneumonia; Staphylococcus aureus; Treatment

Indexed keywords

ARTICLE; BACTERIUM CULTURE; CHILD; CHILD HOSPITALIZATION; CLINICAL ARTICLE; COMMUNITY ACQUIRED PNEUMONIA; FEMALE; HUMAN; HUMAN TISSUE; INTUBATION; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NONHUMAN; PLEURA EFFUSION; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; STAPHYLOCOCCAL PNEUMONIA; STAPHYLOCOCCUS AUREUS; TUBE; UNITED STATES;

ADOLESCENT; AGE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HAWAII; HOSPITALIZATION; HOSPITALS, PEDIATRIC; HUMANS; INCIDENCE; INFANT; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OCEANIC ANCESTRY GROUP; PNEUMONIA, STAPHYLOCOCCAL; RETROSPECTIVE STUDIES;

EID: 77957314503     PISSN: 87556863     EISSN: 10990496     Source Type: Journal    
DOI: 10.1002/ppul.21269     Document Type: Article

References (56)

1. Boyce JM, Causey WA. Increasing occurrence of methicillin-resistant Staphylococcus aureus in the United States. Infect Control 1982;3:377-383.
2. Jarvis WR, Thornsberry C, Boyce J, Hughes JM. Methicillin-resistant Staphylococcus aureus at children's hospitals in the United States. Pediatr Infect Dis 1985;4:651-655.
3. Salgado CD, Farr BM, Calfee DP. Community-acquired methicillin- resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors. Clin Infect Dis 2003;36:131-139. (Pubitemid 36143409)
4. Dietrich DW, Auld DB, Mermel LA. Community-acquired methicillin-resistant Staphylococcus aureus in southern New England children. Pediatrics 2004;113:E347-E352.
5. Frank AL, Marcinak JF, Mangat PD, Schreckenberger PC. Community-acquired and clindamycin-susceptible methicillin-resistant Staphylococcus aureus in children. Pediatr Infect Dis J 1999;18:993-1000.
6. Groom AV, Wolsey DH, Naimi TS, Smith K, Johnson S, Boxrud D, Moore K, Cheek J. Community-acquired methicillin-resistant Staphylococcus aureus in a rural American Indian community. JAMA 2001;286:1201-1205.
7. Herold BC, Immergluck LC, Maranan MC, Lauderdale DS, Gaskin RE, Boyle-Vavra S, Leitch CD, Daum RS. Community-acquired methicillin-resistant Staphylococcus aureus in children with no identified predisposing risk. JAMA 1998;279:593-598.
8. Maguire GP, Arthur AD, Boustead PJ, Dwyer B, Currie BJ. Emerging epidemic of community-acquired methicillin-resistant Staphylococcus aureus infection in the Northern Territory. Med J Aust 1996;164:721-723.
9. Roghman M. Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcal aureus bacteremia. Arch Intern Med 2000;160:1001-1004.
10. Shurland S, Zhan M, Bradham DD, Roghman MC. Comparison of mortality risk associated with bacteremia due to methicillin- resistant and methicillin-susceptible Staphylococcal aureus. Infect Control Hosp Epidemiol 2007;28:273-279. (Pubitemid 46480725)
11. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin-resistance in Staphylococcal aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005;26:166-174.
12. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated methicillin-resistant and methicillin-susceptible Staphylococcal aureus bacteremia: a meta-analysis. Clin Infect Dis 2003;36: 53-59.
13. Chartrand SA, Mccracken GH. Staphylococcal pneumonia in infants and children. Pediatr Infect Dis 1982;1:19-23.
14. Schultz KD, Fan LL, Pinsky J, et al. The changing face of pleural empyemas in children: epidemiology and management. Pediatrics 2004;113:1735-1740.
15. Alfaro C, Fergie J, Purcell K. Emergence of community-acquired methicillin-resistant Staphylococcocus aureus in complicated parapneumonic effusions. Pediatr Infect Dis J 2005;24:274-276.
16. Buckingham SC, King MD, Miller ML. Incidence and etiologies of complicated parapneumonia effusions in children, 1996-2001. Pediatr Infect Dis J 2003;22:499-504.
17. Magotra ML, Andurkar GP, Narayanaswamy AS. Staphylococcal pneumonia in children: an analysis of 30 cases. Indian J Pediatr 1974;41:1-6.
18. Singla R, Singh P, Bhagi RP, Singh PP. Pleuropulmonary complications of staphylococcal pulmonary infection in children. Indian J Chest Dis Allied Sci 1989;31:151-157.
19. Knight GJ, Carman PG. Primary staphylococcal pneumonia in childhood: a review of 69 cases. J Paediatr Child Health 1992; 28:447-450. (Pubitemid 23004368)
20. Goel A, Bamford L, Hanslo D, Hussey G. Primary staphylococcal pneumonia in young children: a review of 100 cases. J Trop Pediatr 1999;45:233-236.
21. Gonzalez C, Rubio M, Romera-Vivas J, Gonzalez M, Picazo JJ. Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillinsusceptible organisms. Clin Infect Dis 1999;29:1171-1177.
22. Profile of General Demographic Characteristics: 2000. [Internet]. U.S. Census Bureau; [cited 2010 Feb 5]. Available from http://factfinder.census.gov/ servlet/QTTable?-bm=y&-geo-id= 04000US15&-qr-name=DEC-2000-SF1-U- DP1&-ds-name= DEC-2000-SF1-U&--lang=en&--sse=on.
23. Centers for Disease Control and Prevention Community-associated methicillin-resistant Staphylococcus aureus infections in Pacific Islanders-Hawaii, 2001-2003. MMWR 2004;53:767-770.
24. Estivariz CF, Park SY, Hageman JC, Dvorin J, Melish MM, Arpon R, Coon P, Slavish S, Kim M, McDougal LK, Jensen B, McAllister S, Lonsway D, Killgore G, Effler PE, Jernigan DB. Emergence of community-associated methicillin resistant Staphylococcus aureus in Hawaii, 2001-2003. J Infect 2007;54:349-357.
25. Active Bacterial Core Surveillance (ABCs) Report Emerging Infections Program Network Methicillin-Resistant Staphylococcus aureus, 2008 [Internet]. CDC; [cited 2010 Feb 5]. Available from http://www.cdc.gov/abcs/reports- findings/survreports/mrsa08. pdf.
26. Bartlett JG, Mundy LM. Community acquired pneumonia. N Engl J Med 1995;333:1618-1624.
27. Centers for Disease Control and Prevention. Four pediatric deaths from community-acquired methicillin-resistant Staphylococcus aureus-Minnesota and North Dakota, 1997-1999. JAMA 1999; 282:1123-1125.
28. Fridkin SK, Hageman JC, Morrison M, Sanza LT, Como-Sabetti K, Jernigan JA, Harriman K, Harrison LH, Lynfield R, Farley M. Methicillin-resistant Staphylococcus aureus disease in three communities. N Engl J Med 2005;352:1436-1444.
29. Francis JS, Doherty MC, Lopatin U, Johnston CP, Singha G, Ross T, Cai M, Hansel NM, Perl T, Ticehurst JR, Carroll K, Thomas DL, Neuemberger E, Bartlett JG. Severe community-onset pneumonia in healthy adults caused by methicillin-resistant Staphylococcus aureus carrying the Panton-Valentine leukocidin genes. Clin Infect Dis 2005;40:100-107. (Pubitemid 40053465)
30. Hageman JC, Uyeki TM, Francis JS, Jernigan DB, Wheeler JG, Bridges CB, Barenkamp SJ, Sievert DM, Srinvansan A, Doherty MC, McDougal LK, Killgore GE, Lopatin UA, Coffman R, MacDonald JK, McAllister SK, Fosheim GE, Patel JB, MacDonald LC. Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis 2006;12:894-899.
31. Centers for Disease Control and Prevention (CDC). Severe methicillin-resistant Staphylococcus aureus community-acquired pneumonia associated with influenza-Louisiana and Georgia, December 2006-January 2007. MMWR 2007;56:325-329.
32. Micek ST, Dunne M, Kollef MH. Pleuropulmonary complications of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus: importance of treatment with antimicrobials inhibiting exotoxin production. Chest 2005;128:2732-2738.
33. Frazee BW, Salz TO, Lambert L, Perdreau-Remington F. Fatal community-associated methicillin-resistant Staphylococcus aureus pneumonia in an immunocompetent young adult. Ann Emerg Med 2005;46:401-404. (Pubitemid 41552385)
34. Tong SYC, Bizhop EJ, Lilliebridge RA, Cheng AC, Spasova-Penkova Z, Holt DC, Giffard PM, McDonald MI, Currie BJ, Boutlis CS. Community-associated strains of methicillin-resistant Staphylococcus aureus and methicillin-susceptible Staphylococcus aureus in indigenous Northern Australia: epidemiology and outcomes. J Infect Dis 2009;199:1461-1470.
35. Turnidge JD. High burden of staphylococcal disease in indigenous communities. J Infect Dis 2009;199:1416-1418.
36. Miles F, Vozz L, Segedin E, Anderson BJ. Review of Staphylococcus aureus infections requiring admission to a paediatric intensive care unit. Arch Dis Child 2005;90:1274-1278.
37. Hill PC, Birch M, Chambers S, Drinkovic D, Ellis-Pegler RB, Everts R, Murdoch D, Pottumarthy S, Roberts SA, Swager C, Taylor SL, Thomas MG, Wong CG, Morris AJ. Prospective study of 424 cases of Staphylococcal bacteremia: determination of factors affecting incidence and mortality. Intern Med J 2001;31: 97-103.
38. Collignon P, Gosbell I, Vickery A, Nimmo G, Stylianopoulos T, Gottlieb T. Community-acquired methicillin-resistant Staphylococcus aureus in Australia. Lancet 1998;352:145-146.
39. Seifried SE, Tice AD, Eischen M. Diversity of community-associated strains of methicillin-resistant Staphylococcus aureus in Hawaii. J Infect Dis 2007;195:305.
40. Morita JE, Fujioka RS, Tice AD, Berestecky J, Sato D, Seifried SE, Katz AR. Survey of methicillin-resistant Staphylococcus aureus (MRSA) carriage in healthy college students, Hawai'i. Hawaii Med J 2007;66:213-215.
41. Ochoa TJ, Mohr J, Wanger A, Murphy JR, Heresi GP. Community-associated methicillin-resistant Staphylococcal aureus in pediatric patients. Emerg Infect Dis 2005;11:966-968.
42. Martinez-Aguilar G, Hammerman WA, Mason EO, Kaplan SL. Clindamycin treatment of invasive infections caused by community-acquired, methicillin-resistant and methicillin-susceptible Staphylococcal aureus in children. Pediatr Infect Dis J 2003;22: 593-598.
43. Carbon C. Costs of treating infections caused by methicillin-resistant staphylococci and vancomycin-resistant enterococci. J Antimicrob Chemother 1999;44:31-36. (Pubitemid 29425490)
44. Kopp BJ, Nix DE, Armstrong EP. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmacother 2004;38:1377-1382.
45. Shorr AF. Epidemiology and economic impact of methicillin-resistant Staphylococcus aureus. Pharmacoeconomics 2007;25: 751-768.
46. Lodise TP, McKinnon PS. Clinical and economic impact of methicillin resistance in patients with Staphylococcus aureus bacteremia. Diagn Microbiol Infect Dis 2005;52:113-122.
47. Shorr AF, Tabak YP, Gupta V, Johannes RS, Liu LZ, Kollef MH. Morbidity and cost burden of methicillin-resistant Staphylococcus aureus in early onset ventilator-associated pneumonia. Crit Care 2006;10:R97.
48. Ott E, Graf F, Schwab F, Reichardt C, Chaberny IF. Costs of nosocomial methicillin-resistant Staphylococcus aureus pneumonia. European Congress of Clinical Microbiology and Infectious Diseases 2009; p. P1894.
49. Anderson D, Kaye K, Chen L, Schmader K, Choi Y, Sloane R, Sexton D. Clinical and financial outcomes due to methicillin resistant Staphylococcus aureus surgical site infection: a multi-center matched outcomes study. PLoS ONE 2009;4: e8305.
50. Noskin G, Rubin R, Schentag J, Kluytmans J, Hedblom E, Jacobson C, Smulders M, Gemmen E, Bharmal M. National trends in Staphylococcus aureus infection rates: impact on economic burden and mortality over a 6-year period (1998-2003). Clin Infect Dis 2007;45:1132-1140.
51. Kopp B, Nix D, Armstrong E. Clinical and economic analysis of methicillin-susceptible and -resistant Staphylococcus aureus infections. Ann Pharmocother 2004;38:1377-1382.
52. Tenover FC, Goering RV. Methicillin-resistant Staphylococcus aureus strain US A300: origin and epidemiology. J Antimicrob Chemother 2009;64:441-446.
53. Bubeck Wardenburg J, Palazzolo-Ballance AM, Otto M, Schneewind O, DeLeo FR. Panton-Valentine leukocidin is not a virulence determinant in murine models of community-associated methicillin-resistant Staphylococcus aureus disease. J Infect Dis 2008;198:1166-1170.
54. Moskowitz SM, Wiener-Kronish JP. Mechanisms of bacterial virulence in pulmonary infections. Curr Opin Crit Care 2010;16: 8-12.
55. Mongkolrattanothai K, Aldag JC, Mankin P, Gray BM. Epidemiology of community-onset Staphylococcus aureus infections in pediatric patients: an experience at a Children's Hospital in central Illinois. BMC Infect Dis 2009;9:2334-2339.
56. Jacobsson G, Dashti S, Wahlberg T, Andersson R. The epidemiology and risk factors for invasive Staphylococcus aureus infections in western Sweden. Scand J Infect Dis 2007;39:6-13. (Pubitemid 46277141)